February 19, 2025
The European Commission has approved nemolizumab (Nemluvio) for subcutaneous use in treating moderate to severe atopic dermatitis (AD) in patients aged ≥ 12 years and moderate […]
February 18, 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for nemolizumab (Nemluvio, Galderma) to treat moderate to severe prurigo nodularis in adults and […]
February 14, 2025
The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA) has started a review of medicines containing finasteride and dutasteride following concerns about associated suicidal […]
February 13, 2025
TOPLINE: About 1 in 15 solid organ transplant patients per year develop actinic keratosis (AK), with men, White individuals, and lung transplant recipients at highest risk. […]
February 12, 2025
TOPLINE: Immune checkpoint inhibitors (ICIs) show promise for field cancerization, based on their ability to reduce actinic keratoses (AKs) in a new study. METHODOLOGY: This prospective […]
February 12, 2025
Individuals on immunosuppressants should discontinue them prior to patch testing, if at all possible, to avoid tarnishing the test results, according to updated guidelines from the […]
February 10, 2025
CORONADO, Calif. — Despite recent advances in the treatment of cutaneous squamous cell carcinoma (SCC), a lack of consensus remains on what defines high-risk disease, according […]
February 7, 2025
CORONADO, Calif. — Advances in adjuvant and neoadjuvant systemic therapies are continuing to improve recurrence-free and distant metastasis-free survival rates in patients with advanced melanoma. Kathryn […]
February 7, 2025
TOPLINE: A review of the top 50 TikTok videos about spironolactone for treating acne revealed that most were patient testimonials, with overall poor reliability and quality […]